| The 8th Asian Pacific Association for the Study of the Liver Single Topic Conference |
 |
| Date: 7th (Fri) - 9th (Sun) October, 2011 Venue: China National Convention Center (CNCC) No. 7, Tianchen East Road, Chaoyang District, Beijing 100105, China www.cnccchina.com Official Language: English Conference Secretariat: Cosoman Limited Room 1B, 5/F., Loyong Court Commercial Building, 212 - 220 Lockhart Road, Wanchai, Hong Kong Tel: +852 2827 2012 Fax: +852 2827 2220 Email: [email protected] |
Category | Early Registration | Late Registration | On-site Registration |
(~September 01) | (September 02~30) | (October 7~9) | |
APASL Member | US$ 150 | US$ 200 | US$ 250 |
Presenter of Accepted Abstracts | US$ 150 | US$ 150 | US$ 250 |
Non-member | US$ 300 | US$ 350 | US$ 400 |
Trainee/Resident | US$ 100 | US$ 150 | US$ 200 |
Chinese Delegate | RMB ¥ 1,000 | RMB ¥ 1,500 | RMB ¥ 2,000 |
Accompanying Person | US$ 150 | ||
Dear colleagues, Liver diseases progression including Chronic Hepatitis B, Liver Cirrhosis, Liver Failure and HCC, this progression is driven by two major factors: virological and immunological factors. However, there are many challenges and unanswered questions in clinical immunology of liver diseases which is becoming one of the hot topics in gastroenterology and hepatology. This conference will invite the prestigious experts of liver immunology and immunotherapy to give us comprehensive and cutting-edge presentations, not only in basic research but also the clinical studies in viral hepatitis B and related liver diseases. In addition, the scientific program also includes the application of vaccines, diagnosis and therapies. Therefore, we hope to capture the updated research findings and translate the scientific evidence into better patient management of liver diseases. If you are working in the field of liver diseases, you should not miss this great opportunity to share with us your insights in Liver Immunology. Yours turly, | |||||||||||||
| |||||||||||||
| |||||||||||||
|
| Scientific Program - 7 October, 2011 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Scientific Program - 8 October, 2011 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Day 3 (Oct 9, 2011) | ||
07:30 - 08:30 | Oral Presentation 4 (OP4) | |
Meeting Room 306A | HBV - Basic | |
08:30 - 09:00 | Oral Presentation 5 (OP5) | |
Meeting Room 306B | HCV - Clinical | |
08:30 - 09:00 | Oral Presentation 6 (OP6) | |
Meeting Room 307A | Autoimmune Liver Diseases | |
08:30 - 09:00 | Keynote Lecture 3 (KL3) | |
Meeting Room 309 |
| |
| KL3 | 08:30 - 09:00 | Translational Medicine: Patient Oriented Liver Immunology |
| George K.K. Lau, Hong Kong | ||
09:00 - 10:30 | Official Symposium 9 (OS9) | |
Meeting Room 309 | Immunology and CHB Management | |
| OS9.1 | 09:00 - 09:20 | The role of immune system in viral hepatitis |
| Qin Ning, Wuhan | ||
| OS9.2 | 09:20 - 09:40 | Immunological mechanisms of HBV persistence in newborns, influence of vaccination |
| Shiv K. Sarin, New Delhi | ||
| OS9.3 | 09:40 - 10:00 | Development of preventive and therapeutic vaccines for hepatitis B |
| Daniel Shouval, Israel | ||
| OS9.4 | 10:00 - 10:20 | US perspectives on management of CHB |
| Eddie C. Cheung, Marinez | ||
| 10:20 - 10:30 | Discussion | |
10:30 - 11:00 | Poster Session / Coffee Break | |
|
|
|
11:00 - 12:30 | Official Symposium 10 (OS10) | |
Meeting Room 309 | The Immunology of HCC and Transplantation | |
| OS10.1 | 11:00 - 11:20 | Immunology of liver tumor and T cells |
| Li-Ming Zeng, Guangzhou | ||
| OS10.2 | 11:20 - 11:40 | Association of hepatitis B virus pre-S deletions with the development of hepatocellular carcinoma |
| Byung Chul Yoo, Seoul | ||
| OS10.3 | 11:40 - 12:00 | MicroRNAs as potential diagnostic markers for hepatocellular carcinoma |
| Luc Gailhouste, Tokyo | ||
| OS10.4 | 12:00 - 12:20 | Immune suppression in liver transplantation |
| Chung-Mau Lo, Hong Kong | ||
| 12:20 - 12:30 | Discussion | |
12:30 - 13:30 | Special Lecture (SP) | |
Meeting Room 309 |
| |
| SL1 | 12:30 - 13:00 | Industry Sponsored Clinical Trials in China by Therapeutic Area, Trial Phase, Sponsor and Site Location |
| Johan Karlberg, Hong Kong | ||
12:30 - 13:00 | Closing Remarks | |
Meeting Room 309 |
| |
| OS3.1 | 14:00 - 14:20 | The role of HBV DNA and HBsAg testing |
| Stephen A. Locarnini, Melbourne |
interdetect 发表于 2011-8-31 11:12
回复 StephenW 的帖子
哈哈，是你吗？
| 欢迎光临 肝胆相照论坛 (http://hbvhbv.info/forum/) | Powered by Discuz! X1.5 |
Lanjuan Li, Hangzhou
Yumei Wen, Shanghai
Hui Zhuang, Beijing
Fusheng Wang, Beijing
Jinlin Hou, Guangzhou
Jidong Jia, Beijing
George K.K. Lau, Hong Kong
Lai Wei, Beijing